Miller Anestesia

169. Duncan DJ, Hopkins PM, Harrison SM: Negative

inotropic effects of tumour necrosis factor-alpha

and interleukin-1beta are ameliorated by alfentanil

in rat ventricular myocytes. Br J Pharmacol

150:720–726, 2007.

170. James MK, Vuong A, Grizzle MK, et al: Hemodyna-

mic effects of GI 87084B, an ultra-short acting

-opioid analgesic, in anesthetized dogs. J Pharma-

col Exp Ther 263:84–91, 1992.

171. Weber G, Stark G, Stark U: Direct cardiac electro-

physiologic effects of sufentanil and vecuronium in

isolated guinea-pig hearts. Acta Anaesthesiol Scand

39:1071–1074, 1995.

172. Lischke V, Wilke HJ, Probst S, et al: Prolongation of

the QT-interval during induction of anesthesia in

patients with coronary artery disease. Acta Anaes-

thesiol Scand 38:144–148, 1994.

173. Sharpe MD, Dobkowski WB, Murkin JM, et al:

Alfentanil-midazolam anaesthesia has no electro-

physiological effects upon the normal conduction

system or accessory pathways in patients with

Wolff-Parkinson-White syndrome. Can J Anaesth

39:816–821, 1992.

174. Sharpe MD, Dobkowski WB, Murkin JM, et al: The

electrophysiologic effects of volatile anesthetics and

sufentanil on the normal atrioventricular conduc-

tion system and accessory pathways in Wolff-Par-

kinson-White syndrome. Anesthesiology 80:63–70,

1994.

175. Atlee JL 3rd, Bosnjak ZJ: Mechanisms for cardiac

dysrhythmias during anesthesia. Anesthesiology

72:347–374, 1990.

176. Sarne Y, Flitstein A, Oppenheimer E: Anti-arrhyth-

mic activities of opioid agonists and antagonists and

their stereoisomers. Br J Pharmacol 102:696–698,

1991.

177. McIntosh M, Kane K, Parratt J: Effects of selective

opioid receptor agonists and antagonists during

myocardial ischaemia. Eur J Pharmacol 210:37–44,

1992.

178. Schultz JE, Hsu AK, Gross GJ: Morphine mimics the

cardioprotective effect of ischemic preconditioning

via a glibenclamide-sensitive mechanism in the rat

heart. Circ Res 78:1100–1104, 1996.

179. Zhang Y, Irwin MG, Wong TM, et al: Remifentanil

preconditioning confers cardioprotection via

cardiac

- and

-opioid receptors. Anesthesiology

102:371–378, 2005.

180. Zhang Y, Irwin MG, Wong TM: Remifentanil pre-

conditioning protects against ischemic injury in the

intact rat heart. Anesthesiology 101:918–923,

2004.

181. Frassdorf J, Weber NC, Obal D, et al: Morphine

induces late cardioprotection in rat hearts in vivo:

The involvement of opioid receptors and nuclear

transcription factor

B. Anesth Analg 101:934–941,

2005.

182. Zhang SZ, Wang NF, Xu J, et al:

-Opioid receptors

mediate cardioprotection by remote preconditio-

ning. Anesthesiology 105:550–556, 2006.

183. Weihrauch D,Krolikowski JG,Bienengraeber M,et al:

Morphine enhances isoflurane-induced postcondi-

tioning against myocardial infarction: The role of

phosphatidylinositol-3-kinase and opioid receptors

in rabbits. Anesth Analg 101:942–949, 2005.

184. McPherson BC, Yao Z: Signal transduction of

opioid-induced cardioprotection in ischemia-reper-

fusion. Anesthesiology 94:1082–1088, 2001.

185. Kato R, Foex P: Fentanyl reduces infarction but not

stunning via

-opioid receptors and protein kinase

C in rats. Br J Anaesth 84:608–614, 2000.

186. Kato R, Ross S, Foex P: Fentanyl protects the heart

against ischaemic injury via opioid receptors, ade-

nosine A

receptors and K

ATP

channel linked mecha-

nisms in rats. Br J Anaesth 84:204–214, 2000.

187. Warltier DC, Pagel PS, Kersten JR: Approaches to

the prevention of perioperative myocardial ische-

mia. Anesthesiology 92:253–259, 2000.

188. Helman JD, Leung JM, Bellows WH, et al: The risk

of myocardial ischemia in patients receiving desflu-

rane versus sufentanil anesthesia for coronary artery

bypass graft surgery. The S.P.I. Research Group.

Anesthesiology 77:47–62, 1992.

189. Leung JM, Goehner P, O’Kelly BF, et al: Isoflurane

anesthesia and myocardial ischemia: Comparative

risk versus sufentanil anesthesia in patients under-

going coronary artery bypass graft surgery. The SPI

(Study of Perioperative Ischemia) Research Group.

Anesthesiology 74:838–847, 1991.

190. Blaise GA, Witzeling TM, Sill JC, et al: Fentanyl is

devoid of major effects on coronary vasoreactivity

and myocardial metabolism in experimental

animals. Anesthesiology 72:535–541, 1990.

191. Moore PG, Quail AW, Cottee DB, et al: Effect of

fentanyl on baroreflex control of circumflex coro-

nary conductance. Clin Exp Pharmacol Physiol

27:1028–1033, 2000.

192. Yamanoue T, Brum JM, Estafanous FG, et al: Effects

of opioids on vasoresponsiveness of porcine coro-

nary artery. Anesth Analg 74:889–896, 1992.

193. Lennander O, Henriksson BA, Martner J, Biber B:

Effects of fentanyl, nitrous oxide, or both, on baro-

receptor reflex regulation in the cat. Br J Anaesth

77:399–403, 1996.

194. Arnold RW, Jensen PA, Kovtoun TA, et al: The pro-

found augmentation of the oculocardiac reflex by

fast acting opioids. Binocul Vis Strabismus Q

19:215–222, 2004.

195. Hahnenkamp K, Honemann CW, Fischer LG, et al:

Effect of different anaesthetic regimes on the oculo-

cardiac reflex during paediatric strabismus surgery.

Paediatr Anaesth 10:601–608, 2000.

196. Blunk JA, Schmelz M, Zeck S, et al: Opioid-induced

mast cell activation and vascular responses is not

mediated by

-opioid receptors: An in vivo micro-

dialysis study in human skin. Anesth Analg 98:364–

370, 2004.

197. Stefano GB: Autoimmunovascular regulation: Mor-

phine and anandamide and ancondamide stimula-

ted nitric oxide release. J Neuroimmunol 83:70–76,

1998.

198. White DA, Reitan JA, Kien ND, Thorup SJ:

Decrease in vascular resistance in the isolated

canine hindlimb after graded doses of alfentanil,

fentanyl, and sufentanil. Anesth Analg 71:29–34,

1990.

199. Ebert TJ, Ficke DJ,Arain SR, et al:Vasodilation from

sufentanil in humans.Anesth Analg 101:1677–1680,

2005.

200. Sohn JT, Park KE, Kim C, et al: Alfentanil attenuates

phenylephrine-induced contraction in rat aorta.

Eur J Anaesthesiol 24:276–282, 2007.

201. Unlugenc H, Itegin M, Ocal I, et al: Remifentanil

produces vasorelaxation in isolated rat thoracic

aorta strips. Acta Anaesthesiol Scand 47:65–69,

2003.

202. Sohn JT, Ding X, McCune DF, et al: Fentanyl atte-

nuates

-adrenoceptor–mediated pulmonary

artery contraction. Anesthesiology 103:327–334,

2005.

203. Kaye AD, Baluch A, Phelps J, et al: An analysis of

remifentanil in the pulmonary vascular bed of the

cat. Anesth Analg 102:118–123, 2006.

204. Kaye AD, Phelps J, Baluch A, et al: The effects of

sufentanil in the feline pulmonary vascular bed. Eur

J Pharmacol 534:159–164, 2006.

205. Sohn JT, Ok SH, Kim HJ, et al: Inhibitory effect of

fentanyl on acetylcholine-induced relaxation in rat

aorta. Anesthesiology 101:89–96, 2004.

206. Chrousos GP, Gold PW: The concepts of stress and

stress system disorders. Overview of physical and

behavioral homeostasis. JAMA 267:1244–1252,

1992.

207. Anand KJ, Hansen DD, Hickey PR: Hormonal-

metabolic stress responses in neonates undergoing

cardiac surgery. Anesthesiology 73:661–670, 1990.

208. Delitala G, Trainer PJ, Oliva O, et al: Opioid peptide

and

-adrenoceptor pathways in the regulation of

the pituitary-adrenal axis in man. J Endocrinol

141:163–168, 1994.

209. Ellis DJ, Steward DJ: Fentanyl dosage is associated

with reduced blood glucose in pediatric patients

after hypothermic cardiopulmonary bypass. Anes-

thesiology 72:812–815, 1990.

210. Myles PS, Hunt JO, Fletcher H, et al: Remifentanil,

fentanyl, and cardiac surgery: A double-blinded,

randomized, controlled trial of costs and outcomes.

Anesth Analg 95:805–812, 2002.

211. Anand KJ, Hickey PR: Halothane-morphine com-

pared with high-dose sufentanil for anesthesia and

postoperative analgesia in neonatal cardiac surgery.

N Engl J Med 326:1–9, 1992.

212. Mangano DT, Siliciano D, Hollenberg M, et al:

Postoperative myocardial ischemia. Therapeutic

trials using intensive analgesia following surgery.

The Study of Perioperative Ischemia (SPI) Research

Group. Anesthesiology 76:342–353, 1992.

213. Plunkett JJ, Reeves JD, Ngo L, et al: Urine and

plasma catecholamine and cortisol concentrations

after myocardial revascularization. Modulation by

continuous sedation. Multicenter Study of Periope-

rative Ischemia (McSPI) Research Group, and the

Ischemia Research and Education Foundation

(IREF). Anesthesiology 86:785–796, 1997.

214. Nestler EJ, Aghajanian GK: Molecular and cellular

basis of addiction. Science 278:58–63, 1997.

215. Chan KW, Duttory A, Yoburn BC: Magnitude of

tolerance to fentanyl is independent of

-opioid

receptor density. Eur J Pharmacol 319:225–228,

1997.

216. Lim G, Wang S, Zeng Q, et al: Spinal glucocorticoid

receptors contribute to the development of mor-

phine tolerance in rats.Anesthesiology 102:832–837,

2005.

217. Wang Y, Mitchell J, Moriyama K, et al: Age-depen-

dent morphine tolerance development in the rat.

Anesth Analg 100:1733–1739, 2005.

218. Kissin I, Brown PT, Robinson CA, Bradley EL Jr:

Acute tolerance in morphine analgesia: Continuous

infusion and single injection in rats.Anesthesiology

74:166–171, 1991.

219. Chia YY, Liu K, Wang JJ, et al: Intraoperative high

dose fentanyl induces postoperative fentanyl tole-

rance. Can J Anaesth 46:872–877, 1999.

220. Vinik HR, Kissin I: Rapid development of tolerance

to analgesia during remifentanil infusion in humans.

Anesth Analg 86:1307–1311, 1998.

221. Guignard B, Bossard AE, Coste C, et al: Acute

opioid tolerance: Intraoperative remifentanil increa-

ses postoperative pain and morphine requirement.

Anesthesiology 93:409–417, 2000.

222. Schraag S, Checketts MR, Kenny GN: Lack of rapid

development of opioid tolerance during alfentanil

and remifentanil infusions for postoperative pain.

Anesth Analg 89:753–757, 1999.

223. Gustorff B, Nahlik G, Hoerauf KH, Kress HG: The

absence of acute tolerance during remifentanil infu-

sion in volunteers. Anesth Analg 94:1223–1228,

2002.

584

Farmacología y anestesia